Modified Bismuth Nanoparticles: A New Targeted Nanoprobe for Computed Tomography Imaging of Cancer

Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a major problem. In this study, we explain the ability of Triptorelin peptide-targeted multifunctional bismuth nanoparticles (Bi2S3@ BSA-Triptore...

Full description

Saved in:
Bibliographic Details
Published inCell journal (Yakhteh) Vol. 24; no. 9; pp. 515 - 521
Main Authors Mohammadi, Milad, Khademi, Sara, Choghazrdi, Yazdan, Irajirad, Rasoul, Keshtkar, Mohammad, Montazerabadi, Alireza
Format Journal Article
LanguageEnglish
Published Tehran Royan Institute of Iran 01.09.2022
Royan Institute (ACECR), Tehran
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a major problem. In this study, we explain the ability of Triptorelin peptide-targeted multifunctional bismuth nanoparticles (Bi2S3@ BSA-Triptorelin NPs) for molecular CT imaging. Materials and Methods: In this experimental study, the formed nanocomplex of Bi2S3@ BSA-Triptorelin NPs was characterized using different methods. The MTT cytotoxicity test was performed to determine the appropriate concentration of nanoparticles in the MCF-7 cells. The X-ray attenuation intensity and Contrast to Noise Ratio (CNR) of targeted and non-targeted nanoparticles were measured at the concentrations of 25, 50, and 75 μg/ml and X-ray tube voltages of 90, 120 and 140 kVp. Results: We showed that the formed Bi2S3@ BSA-Triptorelin NPs with a Bi core size of approximately ~8.6 nm are nontoxic in a given concentration (0-200 μg/ml). At 90, 120, and 140 tube potentials (kVp), the X-ray attenuation of targeted cells were 1.35, 1.36, and 1.33-times, respectively, more than non-targeted MCF-7cells at the concentration of 75 μg/ml. The CNR values at 90, 120, and 140 kVp tube potentials were 171.5, 153.8 and 146.3 c/ϭ, respectively. Conclusion: These findings propose that the diagnostic nanocomplex of Bi2S3@ BSA-Triptorelin NPs can be applied as a good contrast medium for molecular CT techniques.
AbstractList OBJECTIVERecently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a major problem. In this study, we explain the ability of Triptorelin peptide-targeted multifunctional bismuth nanoparticles (Bi2S3@ BSA-Triptorelin NPs) for molecular CT imaging. MATERIALS AND METHODSIn this experimental study, the formed nanocomplex of Bi2S3@ BSA-Triptorelin NPs was characterized using different methods. The MTT cytotoxicity test was performed to determine the appropriate concentration of nanoparticles in the MCF-7 cells. The X-ray attenuation intensity and Contrast to Noise Ratio (CNR) of targeted and non-targeted nanoparticles were measured at the concentrations of 25, 50, and 75 μg/ml and X-ray tube voltages of 90, 120 and 140 kVp. RESULTSWe showed that the formed Bi2S3@ BSA-Triptorelin NPs with a Bi core size of approximately ~8.6 nm are nontoxic in a given concentration (0-200 μg/ml). At 90, 120, and 140 tube potentials (kVp), the X-ray attenuation of targeted cells were 1.35, 1.36, and 1.33-times, respectively, more than non-targeted MCF-7cells at the concentration of 75 μg/ml. The CNR values at 90, 120, and 140 kVp tube potentials were 171.5, 153.8 and 146.3 c/ϭ, respectively. CONCLUSIONThese findings propose that the diagnostic nanocomplex of Bi2S3@ BSA-Triptorelin NPs can be applied as a good contrast medium for molecular CT techniques.
Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computedtomography (CT) imaging of cancer cells stays a major problem. In this study, we explain the ability of Triptorelinpeptide-targeted multifunctional bismuth nanoparticles (Bi2S3@ BSA-Triptorelin NPs) for molecular CT imaging.Materials and Methods: In this experimental study, the formed nanocomplex of Bi2S3@ BSA-Triptorelin NPswas characterized using different methods. The MTT cytotoxicity test was performed to determine the appropriateconcentration of nanoparticles in the MCF-7 cells. The X-ray attenuation intensity and Contrast to Noise Ratio (CNR) oftargeted and non-targeted nanoparticles were measured at the concentrations of 25, 50, and 75 μg/ml and X-ray tubevoltages of 90, 120 and 140 kVp.Results: We showed that the formed Bi2S3@ BSA-Triptorelin NPs with a Bi core size of approximately ~8.6 nm are nontoxicin a given concentration (0-200 μg/ml). At 90, 120, and 140 tube potentials (kVp), the X-ray attenuation of targeted cells were1.35, 1.36, and 1.33-times, respectively, more than non-targeted MCF-7cells at the concentration of 75 μg/ml. The CNRvalues at 90, 120, and 140 kVp tube potentials were 171.5, 153.8 and 146.3 c/ϭ, respectively.Conclusion: These findings propose that the diagnostic nanocomplex of Bi2S3@ BSA-Triptorelin NPs can be appliedas a good contrast medium for molecular CT techniques.
Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a major problem. In this study, we explain the ability of Triptorelin peptide-targeted multifunctional bismuth nanoparticles (Bi2S3@ BSA-Triptorelin NPs) for molecular CT imaging. Materials and Methods: In this experimental study, the formed nanocomplex of Bi2S3@ BSA-Triptorelin NPs was characterized using different methods. The MTT cytotoxicity test was performed to determine the appropriate concentration of nanoparticles in the MCF-7 cells. The X-ray attenuation intensity and Contrast to Noise Ratio (CNR) of targeted and non-targeted nanoparticles were measured at the concentrations of 25, 50, and 75 μg/ml and X-ray tube voltages of 90, 120 and 140 kVp. Results: We showed that the formed Bi2S3@ BSA-Triptorelin NPs with a Bi core size of approximately ~8.6 nm are nontoxic in a given concentration (0-200 μg/ml). At 90, 120, and 140 tube potentials (kVp), the X-ray attenuation of targeted cells were 1.35, 1.36, and 1.33-times, respectively, more than non-targeted MCF-7cells at the concentration of 75 μg/ml. The CNR values at 90, 120, and 140 kVp tube potentials were 171.5, 153.8 and 146.3 c/ϭ, respectively. Conclusion: These findings propose that the diagnostic nanocomplex of Bi2S3@ BSA-Triptorelin NPs can be applied as a good contrast medium for molecular CT techniques.
Author Mohammadi, Milad
Khademi, Sara
Keshtkar, Mohammad
Irajirad, Rasoul
Choghazrdi, Yazdan
Montazerabadi, Alireza
Author_xml – sequence: 1
  givenname: Milad
  surname: Mohammadi
  fullname: Mohammadi, Milad
– sequence: 2
  givenname: Sara
  surname: Khademi
  fullname: Khademi, Sara
– sequence: 3
  givenname: Yazdan
  surname: Choghazrdi
  fullname: Choghazrdi, Yazdan
– sequence: 4
  givenname: Rasoul
  surname: Irajirad
  fullname: Irajirad, Rasoul
– sequence: 5
  givenname: Mohammad
  surname: Keshtkar
  fullname: Keshtkar, Mohammad
– sequence: 6
  givenname: Alireza
  surname: Montazerabadi
  fullname: Montazerabadi, Alireza
BookMark eNpdkL1PwzAQxS1UJErpzmiJhaXFvji2w1YqPiqVspQ5cuJzmqqJi5MI9b8nbREDt9zp3dOTfu-aDGpfIyG3nE0BmBIPOe522ykwgKmOhL4gQwDQk1hzMfi7mbwi46bZsn4kA57AkGTv3pauREufyqbq2g1dmdrvTWjLfIfNI53RFX7TtQkFtr3r9A0-Q-p8oHNf7bujvPaVL4LZbw50UZmirAvqHZ2bOsdwQy6d2TU4_t0j8vnyvJ6_TZYfr4v5bDmxIOJ2kmiO3LKI5w4y0Do2XDEds0QAk3nupFYykegAnZVO5gwUR6U0UyZWmc2jEVmcc60323QfysqEQ-pNmZ4EH4r0Fyu1EUoAoThTmUC0iYbMSmbiSGuhTNJn3Z-zetavDps2rcrmWLKp0XdNCgr6aoViqrfe_bNufRfqnjQFHfUEMQgR_QDNg3_s
ContentType Journal Article
Copyright 2022. This work is published under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2022. This work is published under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 3V.
7QL
7T5
7TM
7TO
7U9
7X7
7XB
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
CWDGH
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M7N
M7P
P64
PIMPY
PQEST
PQQKQ
PQUKI
RC3
7X8
DOA
DOI 10.22074/cellj.2022.8348
DatabaseName ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
Middle East & Africa Database
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Biotechnology and BioEngineering Abstracts
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
Genetics Abstracts
MEDLINE - Academic
Directory of Open Access Journals
DatabaseTitle Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
Technology Research Database
ProQuest Central Essentials
Nucleic Acids Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest Central
Genetics Abstracts
Health Research Premium Collection
Middle East & Africa Database
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Collection
AIDS and Cancer Research Abstracts
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Immunology Abstracts
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2228-5814
EndPage 521
ExternalDocumentID oai_doaj_org_article_d3e62247107b4eed982bd60a538847a9
GroupedDBID ---
3V.
5VS
7QL
7T5
7TM
7TO
7U9
7X7
7XB
8FD
8FE
8FH
8FI
8FJ
8FK
AAKDD
ABDBF
ABUWG
ACPRK
ADBBV
AENEX
AFKRA
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C1K
CCPQU
CWDGH
DIK
DWQXO
EBD
EOJEC
ESX
FR3
FYUFA
GNUQQ
GROUPED_DOAJ
H94
HCIFZ
HMCUK
K9.
KQ8
LK8
M48
M7N
M7P
OBODZ
OK1
P64
PGMZT
PIMPY
PQEST
PQQKQ
PQUKI
PROAC
RC3
RNS
RPM
TUS
UKHRP
7X8
ID FETCH-LOGICAL-d245t-981e1d031cf2b2885a17085094206ccf687696ef2efd6f6c0271e77807a57bdc3
IEDL.DBID 7X7
ISSN 2228-5806
IngestDate Tue Oct 22 15:14:42 EDT 2024
Fri Aug 16 22:46:27 EDT 2024
Thu Oct 10 21:58:53 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-d245t-981e1d031cf2b2885a17085094206ccf687696ef2efd6f6c0271e77807a57bdc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.proquest.com/docview/2830855244?pq-origsite=%requestingapplication%
PQID 2830855244
PQPubID 105750
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_d3e62247107b4eed982bd60a538847a9
proquest_miscellaneous_2728144707
proquest_journals_2830855244
PublicationCentury 2000
PublicationDate 2022-09-01
PublicationDateYYYYMMDD 2022-09-01
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-01
  day: 01
PublicationDecade 2020
PublicationPlace Tehran
PublicationPlace_xml – name: Tehran
PublicationTitle Cell journal (Yakhteh)
PublicationYear 2022
Publisher Royan Institute of Iran
Royan Institute (ACECR), Tehran
Publisher_xml – name: Royan Institute of Iran
– name: Royan Institute (ACECR), Tehran
SSID ssj0000602192
Score 2.3023512
Snippet Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a...
OBJECTIVERecently, development of multifunctional contrast agent for effective targeted molecular computed tomography (CT) imaging of cancer cells stays a...
Objective: Recently, development of multifunctional contrast agent for effective targeted molecular computedtomography (CT) imaging of cancer cells stays a...
SourceID doaj
proquest
SourceType Open Website
Aggregation Database
StartPage 515
SubjectTerms Attenuation
Bismuth
Bismuth sulfides
Cancer
Computed tomography
Contrast agents
Contrast media
ct contrast agents
Cytotoxicity
Medical imaging
molecular imaging
Nanoparticles
targeted imaging
Tomography
Toxicity testing
triptorelin
X ray tubes
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PS8MwFA6ykxdRpzidEkG81bVJ86Pe5nBMQU8b7FaSJsEJbWXrDv73vqRVBh68eG1CSfPe-9576cv3ELoBr-B4IVwEroBHKXjcSHNFI6oLLVJFGXWh2uKVzxbp85Itd1p9-Zqwlh643biRoZbDC8ERCp0CoGeSaMNjBYYKwKraq3txtpNMtRgMvit0RPYnHBGTcfePkhDwmSN_KP4OySEhd5L61j-Br_8XHAcfMz1EB11wiMftoo7Qnq2OUX9cQWJcfuJbHMo1wzl4H-mX2qwcBJD4YbUpt80bBqCEDLgrdLvHYwwAhueh0htmhVF_9wdDmIq7Zg4Gz-uyI63GT2XoWIRrhydeF9YnaDF9nE9mUdcwITIkZU2UycQmBsy0cEQTKZlKhKeky1IS86JwHKAv49YR6wwHEUFKmlghZCwUE9oU9BT1qrqyZwgn3KaOUqMTBUGfyJQ1xCptmdGOZKkaoAe_ZflHy4mRe5bq8ABkl3efmv8luwEafm943pnOJveMZJIxCDsG6PpnGJTeC01Vtt7CHEEkZIIiFuf_sY4LtO91oS0dG6Jes97aS4g1Gn0V1OoLaKTPXQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEA4-Ll7EJ64vIoi3apt3BZFVFBX0tAveStIkPnBb3Qfov3eSjXpQvDYl0Mxkvm_SLzMI7QMqeFFLnwEUiIwB4mZGaJpRUxvJNOXUR7XFnbjqs5t7fv9zPTot4OjP1C70k-oPXw7f3z5OYcOfBBkzAQg8Cmfcz5DrEXKoKFOzaJ4wyNODkC-R_WlcBjyLXZLDqUfGVZ7-W_45Sarh_ytER9y5XEKLiTDi7tTCy2jGNStotdtAsjz4wAc4Sjjj2fgqMretffJAKvHZ02gwGT9iCJ6QFSfx2zHuYghquBfV3_BWHA33gTBQV5waPFjcawepkDW-HsQuRrj1-Dz4x3AN9S8veudXWWqikFnC-DgrVeEKC1u39sQQpbguZChTVzKSi7r2AsJhKZwnzlsBZoM0tXBSqlxqLo2t6Tqaa9rGbSBcCMc8pdYUGoigLLWzxGnjuDWelEx30FlYsup1WiejCpWr44N2-FClT60sdQIcBIiNNAwAulTEWJFrCLwAlLrsoO2vBa--vKEKVcoU50BFOmjvexg2QjCablw7gXckUZAdylxu_j_FFloIVp4KxbbR3Hg4cTvALMZmNzrMJ9k_ywQ
  priority: 102
  providerName: Scholars Portal
Title Modified Bismuth Nanoparticles: A New Targeted Nanoprobe for Computed Tomography Imaging of Cancer
URI https://www.proquest.com/docview/2830855244
https://search.proquest.com/docview/2728144707
https://doaj.org/article/d3e62247107b4eed982bd60a538847a9
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwELba5dJLBaVVt8DKSFVvLonf6QXtboEFCVRVi7q3yI5tCtImsI9D_z1jr5ceKvWSSLEVKZ7x982MJzMIfQZWCLJRgQAVSMKBcYmVhhFmG6u4YYKFlG1xIye3_GomZjngtsxplVtMTEDtuibGyE9ioSotBLDR6eMTiV2j4ulqbqHxGu2UtJAxpUvN1EuMpZDAYKkvcoxzEKGLfFJJKTDnSQyNP4CLSOlXzWIDoFS1_x9QTkxzvoveZhMRDzcy3UOvfPsO7Q9bcI_nf_AXnJI2UzR8H9nrzt0HMCPx6H45X69-Y4BL8INzuts3PMQAY3ia8r1hVhqNfwBhMFZxbung8LSb59LV-HKe-hbhLuBx1IjFe3R7fjYdT0hum0Ac5WJFKl360sFmbQK1VGthShUL01UclqhpggQArKQP1AcnQVDgmJZeKV0oI5R1DfuAem3X-o8Il9LzwJizpQHTT1XGO-qN9cLZQCtu-mgUl6x-3FTGqGOt6vSgW9zV-VNrx7wElQBTRlkOlFxpap0sDEAtUKOp-uhwu-B13kDL-q-4--j4ZRhUPwrNtL5bwxxFNfiDqlCf_v-KA_QmSnmTGnaIeqvF2h-BLbGyg6QwA7QzOrv58RPu41_fLyaD5JnD9ZrrZ5cAzGg
link.rule.ids 315,783,787,867,2109,2228,12068,21400,24330,27936,27937,31731,31732,33756,33757,43322,43817,74073,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NTxsxELUKPZRLVUoRKQFcCXFz2bXXH9sLCggU2iSnRMptZa9tmkrZhXwc-PeMHZMekLiurZXWY8-bGc--h9A5oIIXtfQEoECQAhCXGKEZYaY2stCMMx-7LUaiPyl-T_k0FdyWqa3y1SdGR23bOtTILwNRleIc0Ojq8YkE1ahwu5okNHbQx8DDFRQM5FRuayyZAASLusihzkG4ytJNJaWAnJehNP4PUkRKfyoWBIAia_8bpxyR5u4L-pxCRNzb2HQffXDNV3TQayA9nj_jCxybNmM1_ACZYWtnHsJIfD1bztervxjcJeTBqd3tF-5hcGN4HPu9YVYcDX8AYQhWcZJ0sHjczhN1Nb6fR90i3Hp8E3bE4hua3N2Ob_okySYQSwu-IqXKXW7hsNaeGqoU17kMxHRlQTNR116AAyyF89R5K8BQkJjmTkqVSc2lsTU7RLtN27gjhHPhCs-YNbmG0E-W2lnqtHHcGk_LQnfQdViy6nHDjFEFrur4oF08VOlTK8ucgC0BoYw0BUByqaixItPgagEaddlB3dcFr9IBWlb_zd1BP7bDsPWD0XTj2jXMkVRBPigz-f39V5yhT_3xcFAN7kd_jtFesPimTayLdleLtTuBuGJlTuPmeQHykcpW
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwELboIlW9VC1QdQu0Rqq4uZv4nV7QLmUFFFaoWiRukR3blEqbwD4O_PuOvQYOlXqNrUjxPL6Z8ZcZhL4CKgTZqEAACiThgLjESsMIs41V3DDBQmJbTOTpNT-_ETeZ_7TItMonn5gcteuaWCMfxEZVWghAo0HItIirH-Oj-wcSJ0jFm9Y8TuMV2lRcsqKHNkcnk6tfzxWXQgKepSnJsepBhC7yvSWlgKODWCj_Awkjpd80i-OAUg__f1x0wp3xO_Q2B4x4uJbwe7Th2y20PWwhWZ494kOcKJypNr6N7GXn7gIElXh0t5itlr8xOE_IijP57TseYnBqeJrY37Arrcb_gTCErjgPeHB42s1yI2t8NktTjHAX8HHUj_kOuh6fTI9PSR6iQBzlYkkqXfrSgek2gVqqtTClim3qKk4L2TRBgjuspA_UBydBbJCmll4pXSgjlHUN-4B6bdf6jwiX0vPAmLOlgUBQVcY76o31wtlAK276aBSPrL5f98moY-fq9KCb39b5U2vHvAQFgcBGWQ4AXWlqnSwMOF4ASlP10d7TgdfZnBb1i_D76OB5GQwhCs20vlvBHkU1ZIeqUJ_-_4ov6DVoTn1xNvm5i95Ega85Y3uot5yv_D4EGUv7OWvPX9k2z_M
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Modified+Bismuth+Nanoparticles%3A+A+New+Targeted+Nanoprobe+for+Computed+Tomography+Imaging+of+Cancer&rft.jtitle=Cell+journal+%28Yakhteh%29&rft.au=Mohammadi%2C+Milad&rft.au=Khademi%2C+Sara&rft.au=Choghazrdi%2C+Yazdan&rft.au=Irajirad%2C+Rasoul&rft.date=2022-09-01&rft.pub=Royan+Institute+of+Iran&rft.issn=2228-5806&rft.eissn=2228-5814&rft.volume=24&rft.issue=9&rft.spage=515&rft_id=info:doi/10.22074%2Fcellj.2022.8348&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2228-5806&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2228-5806&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2228-5806&client=summon